相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The magnitude and perceived reasons for childhood cancer treatment abandonment in Ethiopia: from health care providers' perspective
Mizan Kiros Mirutse et al.
BMC HEALTH SERVICES RESEARCH (2022)
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
Amar Gajjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Conduct of neuro-oncology multidisciplinary team meetings and closing the gaps in the clinical management of childhood central nervous system tumors in a middle-income country
Jen Chun Foo et al.
CHILDS NERVOUS SYSTEM (2021)
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma
Jeff M. Michalski et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma A Randomized Clinical Trial From the Children's Oncology Group
Sarah E. S. Leary et al.
JAMA ONCOLOGY (2021)
Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country
Nisreen Amayiri et al.
JCO GLOBAL ONCOLOGY (2021)
Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups
Asmaa Mustafa Eid et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2021)
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)
Lucie Lafay-Cousin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Martin Mynarek et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular genetics of medulloblastoma in children: diagnostic, therapeutic and prognostic implications
Maher El Doussouki et al.
FUTURE NEUROLOGY (2019)
Treatment Refusal and Abandonment Remain Major Concerns Despite Good Outcomes with Multi-Modality Management in Pediatric Medulloblastoma: Experience from a Cancer Center in Eastern India
Anirban Das et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2019)
MRI Characteristics of Primary Tumors and Metastatic Lesions in Molecular Subgroups of Pediatric Medulloblastoma: A Single-Center Study
D. Mata-Mbemba et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2018)
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Giles W. Robinson et al.
LANCET ONCOLOGY (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art
Giovanna Stefania Colafati et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Medulloblastoma: From Myth to Molecular
Vijay Ramaswamy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia
Revathi Rajagopal et al.
JOURNAL OF GLOBAL ONCOLOGY (2017)
Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach
Kavneet Kaur et al.
BRAIN PATHOLOGY (2016)
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Dominik Sturm et al.
CELL (2016)
Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma
Chen Wang et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2016)
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy
Lucie Lafay-Cousin et al.
PEDIATRIC BLOOD & CANCER (2016)
Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey
Paola Friedrich et al.
PLOS ONE (2016)
Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape
Amar Gajjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours
Maria Lastowska et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours
T. Goschzik et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch et al.
ACTA NEUROPATHOLOGICA (2014)
MRI Surrogates for Molecular Subgroups of Medulloblastoma
S. Perreault et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031)
Nancy J. Tarbell et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Vijay Ramaswamy et al.
LANCET ONCOLOGY (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology
Andre O. von Bueren et al.
NEURO-ONCOLOGY (2011)
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
David W. Ellison et al.
JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE (2011)
Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective
Martin J. van den Bent
ACTA NEUROPATHOLOGICA (2010)
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the Head Start I and II protocols
Girish Dhall et al.
PEDIATRIC BLOOD & CANCER (2008)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
